1. E.S. Vesell, 1991, The model drug approach in clinical pharmacology, Clin. Pharmacol. Ther. 50:239–248.
2. E.S. Vesell, 1979, The antipyrine test in clinical pharmacology: Conceptions and misconceptions, Clin. Pharmacol. Then 26:275–286.
3. B.K. Park, 1982, Assessment of the drug metabolism capacity of the liver, Br. J. Clin. Pharmacol. 14:631–651.
4. M. Hartleb, 1991, Drugs and the liver part II: the role of the antipyrine test in drug metabolism studies, Biopharm. Drug Dispos. 12:559–570.
5. M. Eichelbaum, H.R. Ochs, G.M. Robertz, and A. Somogyi, 1982, Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration, Arzneimittelforschung 32:575–578.